Guangmin Xi

1.2k total citations
20 papers, 893 citations indexed

About

Guangmin Xi is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Guangmin Xi has authored 20 papers receiving a total of 893 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in Guangmin Xi's work include RNA modifications and cancer (5 papers), Inflammasome and immune disorders (4 papers) and Cancer-related molecular mechanisms research (4 papers). Guangmin Xi is often cited by papers focused on RNA modifications and cancer (5 papers), Inflammasome and immune disorders (4 papers) and Cancer-related molecular mechanisms research (4 papers). Guangmin Xi collaborates with scholars based in China, Japan and Thailand. Guangmin Xi's co-authors include Tangfeng Lv, Yong Song, Jianwei Gao, Huiqing Yuan, Xiangyu Qiu, Wujian Xu, Fang Zhang, Ping Zhan, Hongbing Liu and Hanming Jiang and has published in prestigious journals such as The FASEB Journal, Frontiers in Immunology and Molecular Cancer.

In The Last Decade

Guangmin Xi

18 papers receiving 889 citations

Peers

Guangmin Xi
Lianwen Yuan China
Lin An China
Feng‐Yi Mai China
Junhui Yu China
Amine Belaïd France
Jiaming Zhu China
Claudia Meyer Germany
Zhifeng Ning China
Jingshu Geng China
Lianwen Yuan China
Guangmin Xi
Citations per year, relative to Guangmin Xi Guangmin Xi (= 1×) peers Lianwen Yuan

Countries citing papers authored by Guangmin Xi

Since Specialization
Citations

This map shows the geographic impact of Guangmin Xi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangmin Xi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangmin Xi more than expected).

Fields of papers citing papers by Guangmin Xi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guangmin Xi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangmin Xi. The network helps show where Guangmin Xi may publish in the future.

Co-authorship network of co-authors of Guangmin Xi

This figure shows the co-authorship network connecting the top 25 collaborators of Guangmin Xi. A scholar is included among the top collaborators of Guangmin Xi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guangmin Xi. Guangmin Xi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xi, Guangmin, et al.. (2025). Overexpression of PPM1G promotes cell metabolism and activates the NOTCH signaling pathway in lung adenocarcinoma. Translational Lung Cancer Research. 14(7). 2771–2787.
2.
Yang, Xiaomei, Xuyang Wang, Yonghao Hou, et al.. (2025). Osteopontin regulates right ventricular failure through integrin ανβ3/PERK/CHOP-dependent inflammatory and apoptotic pathways. Frontiers in Immunology. 16. 1569210–1569210.
3.
Liu, Luguang, et al.. (2023). OASL knockdown inhibits the progression of stomach adenocarcinoma by regulating the mTORC1 signaling pathway. The FASEB Journal. 37(3). 12 indexed citations
4.
Li, Zuowei, Qiong Fang, Zhiying Li, et al.. (2022). Embelin Enhances the Sensitivity of Renal Cancer Cells to Axitinib by Inhibiting HIFSignaling Pathway. Anti-Cancer Agents in Medicinal Chemistry. 23(7). 807–816. 1 indexed citations
5.
Yu, Jie, et al.. (2022). Luteolin impacts deoxyribonucleic acid repair by modulating the mitogen-activated protein kinase pathway in colorectal cancer. Bioengineered. 13(4). 10998–11011. 25 indexed citations
6.
7.
Xi, Guangmin, Jianwei Gao, Bing Wan, et al.. (2019). GSDMD is required for effector CD8+ T cell responses to lung cancer cells. International Immunopharmacology. 74. 105713–105713. 136 indexed citations
8.
Wan, Bing, Wujian Xu, Ping Zhan, et al.. (2018). Topotecan alleviates ventilator-induced lung injury via NF-κB pathway inhibition. Cytokine. 110. 381–388. 10 indexed citations
9.
Wang, Xiaoxia, Wujian Xu, Ping Zhan, et al.. (2018). Overexpression of geranylgeranyl diphosphate synthase contributes to tumour metastasis and correlates with poor prognosis of lung adenocarcinoma. Journal of Cellular and Molecular Medicine. 22(4). 2177–2189. 25 indexed citations
10.
11.
Zhan, Ping, Bin Zhang, Guangmin Xi, et al.. (2017). PRC1 contributes to tumorigenesis of lung adenocarcinoma in association with the Wnt/β-catenin signaling pathway. Molecular Cancer. 16(1). 108–108. 93 indexed citations
12.
Zhan, Ping, Guangmin Xi, Hongbing Liu, et al.. (2017). Protein regulator of cytokinesis-1 expression: prognostic value in lung squamous cell carcinoma patients. Journal of Thoracic Disease. 9(7). 2054–2060. 13 indexed citations
13.
Wan, Bing, Wujian Xu, Ping Zhan, et al.. (2017). Plasma long noncoding RNA IL‐7R as a prognostic biomarker for clinical outcomes in patients with acute respiratory distress syndrome. The Clinical Respiratory Journal. 12(4). 1607–1614. 14 indexed citations
14.
Yang, Xiaomei, Xiaotong Sun, Hongli Chen, et al.. (2017). The protective effect of dopamine on ventilator-induced lung injury via the inhibition of NLRP3 inflammasome. International Immunopharmacology. 45. 68–73. 23 indexed citations
15.
Xi, Guangmin, Ming Wang, Abdul Sami Shaikh, et al.. (2016). Targeting autophagy augments the activity of DHA-E3 to overcome p-gp mediated multi-drug resistance. Biomedicine & Pharmacotherapy. 84. 1610–1616. 9 indexed citations
16.
Zhan, Ping, Guangmin Xi, Bin Zhang, et al.. (2016). NCAPG2 promotes tumour proliferation by regulating G2/M phase and associates with poor prognosis in lung adenocarcinoma. Journal of Cellular and Molecular Medicine. 21(4). 665–676. 43 indexed citations
17.
Xi, Guangmin, Xiao Hu, Baolin Wu, et al.. (2011). Autophagy inhibition promotes paclitaxel-induced apoptosis in cancer cells. Cancer Letters. 307(2). 141–148. 168 indexed citations
18.
Xi, Guangmin, Bin Sun, Huihui Jiang, et al.. (2010). Bisbibenzyl derivatives sensitize vincristine-resistant KB/VCR cells to chemotherapeutic agents by retarding P-gp activity. Bioorganic & Medicinal Chemistry. 18(18). 6725–6733. 39 indexed citations
19.
Feng, Xiang, Xiao‐Ning Wang, Huiqing Yuan, et al.. (2010). Labdane diterpenoids and highly methoxylated bibenzyls from the liverwort Frullania inouei. Phytochemistry. 71(13). 1573–1578. 24 indexed citations
20.
Sun, Bin, Huiqing Yuan, Guangmin Xi, Yudao Ma, & Hong‐Xiang Lou. (2009). Synthesis and multidrug resistance reversal activity of dihydroptychantol A and its novel derivatives. Bioorganic & Medicinal Chemistry. 17(14). 4981–4989. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lianwen Yuan Breakdown of academic impact, for papers by Lin An Breakdown of academic impact, for papers by Feng‐Yi Mai Breakdown of academic impact, for papers by Junhui Yu Breakdown of academic impact, for papers by Amine Belaïd Breakdown of academic impact, for papers by Jiaming Zhu Breakdown of academic impact, for papers by Claudia Meyer Breakdown of academic impact, for papers by Zhifeng Ning Breakdown of academic impact, for papers by Jingshu Geng
Rankless by CCL
2026